Nilsson MS, Fiegl M, Hiddemann W, Sperr WR, Thorén FB, Martner A, Hellstrand K. Histamine dihydrochloride and low-dose interleukin-2 has anti-leukemic efficacy in <I>NPM1</I&gt;-mutated and myelomonocytic/monocytic acute myeloid leukemia. Haematologica 2024;109(11):3781-3784; https://doi.org/10.3324/haematol.2024.285342.